SCHEMBL2425293

SCHEMBL2425293

O=[N+]([O-])c1ncc2ccoc2c1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 4/20 0.33
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
IDO1 P14902 2/20 0.33
TDO2 P48775 2/20 0.33
CTSB P07858 1/20 0.33
GAA P10253 1/20 0.33
ABCC1 P33527 1/20 0.33
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CASP1 P29466 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
APP P05067 1/20 0.32
GPR35 Q9HC97 1/20 0.32
SLC2A1 P11166 1/20 0.30
CRHBP P24387 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12286482 0.77 CYP1A2 (0.41) ALDH1A1KDM4ECYP2D6CYP2C19HIF1A
SCHEMBL31601596 0.70
SCHEMBL4619852 0.70 CASP6 (0.51) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL3416188 0.69 MGMT (0.38) MAPTMEN1KMT2AIDO1SMN1; SMN2
SCHEMBL3416186 0.69 PARP10 (0.42) MAPTMEN1KMT2AGAALMNA
SCHEMBL2419741 0.69 MAPT (0.38) MAPTKDM4EGAARECQL
SCHEMBL31266928 0.69 NPSR1 (0.40) ALDH1A1KDM4EGAAHSD17B10LMNA
SCHEMBL25806122 0.68 GPR35 (0.39) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL15663592 0.63 KDM4E (0.46) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL3285272 0.63 MAPT (0.49) MAPTALDH1A1KDM4EGAACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265616-B1 FURO-AND THIENO[3,2-C]PYRIDINES OSI PHARM INC (US) 2013-11-20 EP disclosed
US-8022206-B2 Furo[3,2-C]pyridines OSI Pharmaceuticals, LLC (US) 2011-09-20 US disclosed
US-8022206-B2 Furo[3,2-C]pyridines OSI Pharmaceuticals, LLC (US) 2011-09-20 US disclosed
US-8022206-B2 Furo[3,2-C]pyridines OSI Pharmaceuticals, LLC (US) 2011-09-20 US disclosed
EP-2265616-A1 FURO-AND THIENO[3,2-C]PYRIDINES OSI Pharmaceuticals, Inc. (US) 2010-12-29 EP disclosed
WO-2009100282-A1 FURO-AND THIENO[3,2-C] PYRIDINES OSI PHARMACEUTICALS, INC. (US) 2009-08-13 WO disclosed
WO-2009100282-A1 FURO-AND THIENO[3,2-C] PYRIDINES OSI PHARMACEUTICALS, INC. (US) 2009-08-13 WO disclosed
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines OSI PHARMACEUTICALS, INC. 2009-08-06 US disclosed
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines OSI PHARMACEUTICALS, INC. 2009-08-06 US disclosed
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines OSI PHARMACEUTICALS, INC. 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197864-A1 Furo- and Thieno [3,2-c] Pyridines RET, MET, ERBB2 MAPT 1601/4885ALDH1A1 589/4885KDM4E 1230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.